NASDAQ : ISRG
Intuitive Surgical, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 448.76 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 155.56B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 149.75B |
| Enterprise Value | 145.71B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 20, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 346.64M |
| Shares Outstanding | 346.64M |
| Shares Change (YoY) | -1.75% |
| Shares Change (QoQ) | -1.60% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 90.24% |
| Float | 344.60M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 52.22 |
| Forward PE | 35.80 |
| PS Ratio | 12.93 |
| Forward PS | 11.55 |
| PB Ratio | 9.37 |
| P/TBV Ratio | 9.83 |
| P/FCF Ratio | 41.62 |
| P/OCF Ratio | 36.62 |
| PEG Ratio | 2.29 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 49.27 |
| EV / Sales | 12.59 |
| EV / EBITDA | 32.59 |
| EV / EBIT | 39.70 |
| EV / FCF | 40.50 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.33 |
| Quick Ratio | 2.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 17.93% |
| Return on Assets (ROA) | 11.86% |
| Return on Invested Capital (ROIC) | 23.97% |
| Return on Capital Employed (ROCE) | 21.83% |
| Weighted Average Cost of Capital (WACC) | 12.30% |
| Revenue Per Employee | $680,219 |
| Profits Per Employee | $173,738 |
| Employee Count | 17,021 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.98 |
Taxes
| Measure | Value |
|---|
| Income Tax | 645.90M |
| Effective Tax Rate | 17.85% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -19.64% |
| 50-Day Moving Average | 401.54 |
| 200-Day Moving Average | 433.06 |
| Relative Strength Index (RSI) | 54.15 |
| Average Volume (20 Days) | 2,399,185 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.33M |
| Short Previous Month | 7.41M |
| Short % of Shares Out | 2.11% |
| Short % of Float | 2.13% |
| Short Ratio (days to cover) | 3.49 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 11.58B |
| Gross Profit | 7.72B |
| Operating Income | 3.67B |
| Pretax Income | 3.62B |
| Net Income | 2.96B |
| EBITDA | 4.47B |
| EBIT | 3.67B |
| Earnings Per Share (EPS) | $8.27 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.04B |
| Total Debt | n/a |
| Net Cash | 4.04B |
| Net Cash Per Share | $11.66 |
| Equity (Book Value) | 16.12B |
| Book Value Per Share | 46.12 |
| Working Capital | 5.90B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 4.09B |
| Capital Expenditures | -491.50M |
| Depreciation & Amortization | 800.30M |
| Net Borrowing | n/a |
| Free Cash Flow | 3.60B |
| FCF Per Share | $10.38 |
Margins
| Measure | Value |
|---|
| Gross Margin | 66.64% |
| Operating Margin | 31.70% |
| Pretax Margin | 31.26% |
| Profit Margin | 25.54% |
| EBITDA Margin | 38.61% |
| EBIT Margin | 31.70% |
| FCF Margin | 31.08% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.75% |
| Shareholder Yield | 1.75% |
| Earnings Yield | 1.92% |
| FCF Yield | 2.40% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $482.63 |
| Price Target Difference | 11.72% |
| Analyst Consensus | Buy |
| Analyst Count | 34 |
| Revenue Growth Forecast (3Y) | 14.14% |
| EPS Growth Forecast (3Y) | 16.27% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 5, 2021 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 32.46 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |